<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38672973</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4426</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of personalized medicine</Title><ISOAbbreviation>J Pers Med</ISOAbbreviation></Journal><ArticleTitle>Investigating ABO Blood Groups and Secretor Status in Relation to SARS-CoV-2 Infection and COVID-19 Severity.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">346</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jpm14040346</ELocationID><Abstract><AbstractText>The ABO blood groups, Lewis antigens, and secretor systems are important components of transfusion medicine. These interconnected systems have been also shown to be associated with differing susceptibility to bacterial and viral infections, likely as the result of selection over the course of evolution and the constant tug of war between humans and infectious microbes. This comprehensive narrative review aimed to explore the literature and to present the current state of knowledge on reported associations of the ABO, Lewis, and secretor blood groups with SARS-CoV-2 infection and COVID-19 severity. Our main finding was that the A blood group may be associated with increased susceptibility to SARS-CoV-2 infection, and possibly also with increased disease severity and overall mortality. The proposed pathophysiological pathways explaining this potential association include antibody-mediated mechanisms and increased thrombotic risk amongst blood group A individuals, in addition to altered inflammatory cytokine expression profiles. Preliminary evidence does not support the association between ABO blood groups and COVID-19 vaccine response, or the risk of developing long COVID. Even though the emergency state of the pandemic is over, further research is needed especially in this area since tens of millions of people worldwide suffer from lingering COVID-19 symptoms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ferous</LastName><ForeName>Stefanos</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0003-4670-5786</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siafakas</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-0088-143X</Identifier><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Attikon General Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boufidou</LastName><ForeName>Fotini</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-9691-9465</Identifier><AffiliationInfo><Affiliation>Neurochemistry and Biological Markers Unit, 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patrinos</LastName><ForeName>George P</ForeName><Initials>GP</Initials><Identifier Source="ORCID">0000-0002-0519-7776</Identifier><AffiliationInfo><Affiliation>Laboratory of Pharmacogenomics and Individualized Therapy, Department of Pharmacy, School of Health Sciences, University of Patras, 26504 Patras, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Zayed Center for Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsakris</LastName><ForeName>Athanasios</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0656-4715</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anastassopoulou</LastName><ForeName>Cleo</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7666-9198</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Pers Med</MedlineTA><NlmUniqueID>101602269</NlmUniqueID><ISSNLinking>2075-4426</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FUT2</Keyword><Keyword MajorTopicYN="N">Lewis antigens</Keyword><Keyword MajorTopicYN="N">fucosyltransferase</Keyword><Keyword MajorTopicYN="N">histo-blood group antigens (HBGAs)</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">non-secretor phenotype</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38672973</ArticleId><ArticleId IdType="pmc">PMC11051264</ArticleId><ArticleId IdType="doi">10.3390/jpm14040346</ArticleId><ArticleId IdType="pii">jpm14040346</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Karlsson E.K., Kwiatkowski D.P., Sabeti P.C. Natural selection and infectious disease in human populations. Nat. Rev. Genet. 2014;15:379&#x2013;393. doi: 10.1038/nrg3734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3734</ArticleId><ArticleId IdType="pmc">PMC4912034</ArticleId><ArticleId IdType="pubmed">24776769</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckwalter J.A. Disease associations of the ABO blood group. Acta Genet. Stat. Med. 1956;6:561&#x2013;563. doi: 10.1159/000150898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000150898</ArticleId><ArticleId IdType="pubmed">13443820</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindesmith L., Moe C., Marionneau S., Ruvoen N., Jiang X., Lindblad L., Stewart P., LePendu J., Baric R. Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 2003;9:548&#x2013;553. doi: 10.1038/nm860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm860</ArticleId><ArticleId IdType="pubmed">12692541</ArticleId></ArticleIdList></Reference><Reference><Citation>Arifuzzaman M., Ahmed T., Rahman M.A., Chowdhury F., Rashu R., Khan A.I., LaRocque R.C., Harris J.B., Bhuiyan T.R., Ryan E.T., et al. Individuals with Le(a+b-) blood group have increased susceptibility to symptomatic vibrio cholerae O1 infection. PLoS Negl. Trop. Dis. 2011;5:e1413. doi: 10.1371/journal.pntd.0001413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001413</ArticleId><ArticleId IdType="pmc">PMC3246451</ArticleId><ArticleId IdType="pubmed">22216364</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B., Dickson D.M., Decamp A.C., Colgate E.R., Diehl S.A., Uddin M.I., Sharmin S., Islam S., Bhuiyan T.R., Alam M., et al. Histo-Blood Group Antigen Phenotype Determines Susceptibility to Genotype-Specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine Efficacy. J. Infect. Dis. 2018;217:1399&#x2013;1407. doi: 10.1093/infdis/jiy054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiy054</ArticleId><ArticleId IdType="pmc">PMC5894073</ArticleId><ArticleId IdType="pubmed">29390150</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon R.E. Economic costs of respiratory tract infections in the United States. Am. J. Med. 1985;78:45&#x2013;51. doi: 10.1016/0002-9343(85)90363-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(85)90363-8</ArticleId><ArticleId IdType="pubmed">4014287</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira-Coimbra J., Sarda C., Rello J. Burden of Community-Acquired Pneumonia and Unmet Clinical Needs. Adv. Ther. 2020;37:1302&#x2013;1318. doi: 10.1007/s12325-020-01248-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-020-01248-7</ArticleId><ArticleId IdType="pmc">PMC7140754</ArticleId><ArticleId IdType="pubmed">32072494</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization, WHO  COVID-19 Epidemiological Update&#x2014;19 January 2024.  [(accessed on 8 February 2024)].  Available online:  https://www.who.int/publications/m/item/covid-19-epidemiological-update---19-january-2024.</Citation></Reference><Reference><Citation>Boufidou F., Medi&#x107; S., Lampropoulou V., Siafakas N., Tsakris A., Anastassopoulou C. SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic. Int. J. Mol. Sci. 2023;24:12962. doi: 10.3390/ijms241612962.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241612962</ArticleId><ArticleId IdType="pmc">PMC10454552</ArticleId><ArticleId IdType="pubmed">37629143</ArticleId></ArticleIdList></Reference><Reference><Citation>Marionneau S., Cailleau-Thomas A., Rocher J., Le Moullac-Vaidye B., Ruvo&#xeb;n N., Cl&#xe9;ment M., Le Pendu J. ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie. 2001;83:565&#x2013;573. doi: 10.1016/S0300-9084(01)01321-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0300-9084(01)01321-9</ArticleId><ArticleId IdType="pubmed">11522384</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean L.  Blood Groups and Red Cell Antigens [Internet] National Center for Biotechnology Information (US); Bethesda, MD, USA: 2005.  [(accessed on 30 November 2023)].  Chapter 6; The Hh Blood Group. Available online:  https://www.ncbi.nlm.nih.gov/books/NBK2268/</Citation></Reference><Reference><Citation>Koda Y., Soejima M., Liu Y., Kimura H. Molecular basis for secretor type alpha(1,2)-fucosyltransferase gene deficiency in a Japanese population: A fusion gene generated by unequal crossover responsible for the enzyme deficiency. Am. J. Hum. Genet. 1996;59:343&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1914724</ArticleId><ArticleId IdType="pubmed">8755920</ArticleId></ArticleIdList></Reference><Reference><Citation>Oriol R., Candelier J.J., Mollicone R. Molecular genetics of H. Vox Sang. 2000;78((Suppl. S2)):105&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">10938937</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollicone R., Cailleau A., Oriol R. Molecular genetics of H, Se, Lewis and other fucosyltransferase genes. Transfus. Clin. Biol. 1995;2:235&#x2013;242. doi: 10.1016/S1246-7820(05)80089-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1246-7820(05)80089-8</ArticleId><ArticleId IdType="pubmed">8542021</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur P., Gupta M., Sagar V. FUT2 gene as a genetic susceptible marker of infectious diseases: A Review. Int. J. Mol. Epidemiol. Genet. 2022;13:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9301175</ArticleId><ArticleId IdType="pubmed">35892094</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravn V., Dabelsteen E. Tissue distribution of histo-blood group antigens. APMIS Acta Pathol. Microbiol. Immunol. Scand. 2000;108:1&#x2013;28. doi: 10.1034/j.1600-0463.2000.d01-1.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0463.2000.d01-1.x</ArticleId><ArticleId IdType="pubmed">10698081</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniyan R. AB para-Bombay phenotype: A rare blood group variant and its clinical significance. Hematol. Transfus. Cell Ther. 2018;40:96&#x2013;97. doi: 10.1016/j.htct.2017.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.htct.2017.11.003</ArticleId><ArticleId IdType="pmc">PMC6001936</ArticleId><ArticleId IdType="pubmed">30057978</ArticleId></ArticleIdList></Reference><Reference><Citation>Saboor M., Ullah A., Qamar K., Mir A. Frequency of ABH secretors and non secretors: A cross sectional study in Karachi. Pak. J. Med. Sci. 2014;30:189&#x2013;193. doi: 10.12669/pjms.301.4194.</Citation><ArticleIdList><ArticleId IdType="doi">10.12669/pjms.301.4194</ArticleId><ArticleId IdType="pmc">PMC3955570</ArticleId><ArticleId IdType="pubmed">24639859</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L.C., Yang Y.H., Broadberry R.E., Chen Y.H., Chan Y.S., Lin M. Correlation of a missense mutation in the human Secretor alpha 1,2-fucosyltransferase gene with the Lewis(a+b+) phenotype: A potential molecular basis for the weak Secretor allele (Sew) Pt 2Biochem. J. 1995;312:329&#x2013;332. doi: 10.1042/bj3120329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj3120329</ArticleId><ArticleId IdType="pmc">PMC1136267</ArticleId><ArticleId IdType="pubmed">8526839</ArticleId></ArticleIdList></Reference><Reference><Citation>Soejima M., Koda Y. Molecular mechanisms of Lewis antigen expression. Leg. Med. 2005;7:266&#x2013;269. doi: 10.1016/j.legalmed.2004.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.legalmed.2004.12.003</ArticleId><ArticleId IdType="pubmed">15946883</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollicone R., Reguigne I., Kelly R., Fletcher A., Watt J., Chatfield S., Aziz A., Cameron H., Weston B., Lowe J. Molecular basis for Lewis alpha(1,3/1,4)-fucosyltransferase gene deficiency (FUT3) found in Lewis-negative Indonesian pedigrees. J. Biol. Chem. 1994;269:20987&#x2013;20994. doi: 10.1016/S0021-9258(17)31919-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)31919-1</ArticleId><ArticleId IdType="pubmed">8063716</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniyan R. Serological characteristics of Lewis antibodies and their clinical significance&#x2014;A case series. Hematol. Transfus. Cell Ther. 2023;45:159&#x2013;164. doi: 10.1016/j.htct.2021.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.htct.2021.07.007</ArticleId><ArticleId IdType="pmc">PMC10244237</ArticleId><ArticleId IdType="pubmed">34824034</ArticleId></ArticleIdList></Reference><Reference><Citation>May S.J., Blackwell C.C., Weir D.M. Lewis a blood group antigen of non-secretors: A receptor for candida blastospores. FEMS Microbiol. Immunol. 1989;1:407&#x2013;409. doi: 10.1111/j.1574-6968.1989.tb02429.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6968.1989.tb02429.x</ArticleId><ArticleId IdType="pubmed">2631881</ArticleId></ArticleIdList></Reference><Reference><Citation>Jajosky R.P., Wu S.-C., Zheng L., Jajosky A.N., Jajosky P.G., Josephson C.D., Hollenhorst M.A., Sackstein R., Cummings R.D., Arthur C.M., et al. ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies. iScience. 2022;26:105798. doi: 10.1016/j.isci.2022.105798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.105798</ArticleId><ArticleId IdType="pmc">PMC9860303</ArticleId><ArticleId IdType="pubmed">36691627</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N., et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 2020;395:565&#x2013;574. doi: 10.1016/S0140-6736(20)30251-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagliano P., Sellitto C., Conti V., Ascione T., Esposito S. Characteristics of viral pneumonia in the COVID-19 era: An update. Infection. 2021;49:607&#x2013;616. doi: 10.1007/s15010-021-01603-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01603-y</ArticleId><ArticleId IdType="pmc">PMC8006879</ArticleId><ArticleId IdType="pubmed">33782861</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin D.O., Brennan-Rieder D., Ngo B., Kory P., Confalonieri M., Shapiro L., Iglesias J., Dube M., Nanda N., In G.K., et al. The Importance of Understanding the Stages of COVID-19 in Treatment and Trials. AIDS Rev. 2021;23:40&#x2013;47. doi: 10.24875/AIDSRev.200001261.</Citation><ArticleIdList><ArticleId IdType="doi">10.24875/AIDSRev.200001261</ArticleId><ArticleId IdType="pubmed">33556957</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokhtari T., Hassani F., Ghaffari N., Ebrahimi B., Yarahmadi A., Hassanzadeh G. COVID-19 and multiorgan failure: A narrative review on potential mechanisms. J. Mol. Histol. 2020;51:613&#x2013;628. doi: 10.1007/s10735-020-09915-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10735-020-09915-3</ArticleId><ArticleId IdType="pmc">PMC7533045</ArticleId><ArticleId IdType="pubmed">33011887</ArticleId></ArticleIdList></Reference><Reference><Citation>Kutsogiannis D.J., Alharthy A., Balhamar A., Faqihi F., Papanikolaou J., Alqahtani S.A., Memish Z.A., Brindley P.G., Brochard L., Karakitsos D. Mortality and Pulmonary Embolism in Acute Respiratory Distress Syndrome From COVID-19 vs. Non-COVID-19. Front. Med. 2022;9:800241. doi: 10.3389/fmed.2022.800241.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.800241</ArticleId><ArticleId IdType="pmc">PMC8931188</ArticleId><ArticleId IdType="pubmed">35308552</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastassopoulou C., Spanakis N., Tsakris A. SARS-CoV-2 transmission, the ambiguous role of children and considerations for the reopening of schools in the fall. Future Microbiol. 2020;15:1201&#x2013;1206. doi: 10.2217/fmb-2020-0195.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2020-0195</ArticleId><ArticleId IdType="pmc">PMC7469891</ArticleId><ArticleId IdType="pubmed">32878481</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontanet A., Tondeur L., Grant R., Temmam S., Madec Y., Bigot T., Grzelak L., Cailleau I., Besombes C., Ungeheuer M.-N., et al. SARS-CoV-2 infection in schools in a northern French city: A retrospective serological cohort study in an area of high transmission, France, January to April 2020. Euro Surveill. 2021;26:2001695. doi: 10.2807/1560-7917.ES.2021.26.15.2001695.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.15.2001695</ArticleId><ArticleId IdType="pmc">PMC8167414</ArticleId><ArticleId IdType="pubmed">33860747</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones T.C., Biele G., M&#xfc;hlemann B., Veith T., Schneider J., Beheim-Schwarzbach J., Bleicker T., Tesch J., Schmidt M.L., Sander L.E., et al. Estimating infectiousness throughout SARS-CoV-2 infection course. Science. 2021;373:eabi5273. doi: 10.1126/science.abi5273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abi5273</ArticleId><ArticleId IdType="pmc">PMC9267347</ArticleId><ArticleId IdType="pubmed">34035154</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Engin A.B., Engin E.D., Engin A. Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking. Environ. Toxicol. Pharmacol. 2020;78:103411. doi: 10.1016/j.etap.2020.103411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.etap.2020.103411</ArticleId><ArticleId IdType="pmc">PMC7227557</ArticleId><ArticleId IdType="pubmed">32422280</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395:507&#x2013;513. doi: 10.1016/S0140-6736(20)30211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061&#x2013;1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastassopoulou C., Gkizarioti Z., Patrinos G.P., Tsakris A. Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity. Hum. Genom. 2020;14:40. doi: 10.1186/s40246-020-00290-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40246-020-00290-4</ArticleId><ArticleId IdType="pmc">PMC7578581</ArticleId><ArticleId IdType="pubmed">33092637</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Wang X., Chen J., Cai Y., Deng A., Yang M. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia. Br. J. Haematol. 2020;190:24&#x2013;27. doi: 10.1111/bjh.16797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16797</ArticleId><ArticleId IdType="pmc">PMC7267665</ArticleId><ArticleId IdType="pubmed">32379894</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares D.M.B., Ara&#xfa;jo D.A.B.S., Souza J.L.d.B.d., Maur&#xed;cio R.B., Soares E.M.B., Neto F.d.C.A., Pinheiro M.S.N., Gama V.C.d.V., Braga-Neto P., N&#xf3;brega P.R., et al. Correlation between ABO blood type, susceptibility to SARS-CoV-2 infection and COVID-19 disease severity: A systematic review. Hematol. Transfus. Cell Ther. 2023;45:483&#x2013;494. doi: 10.1016/j.htct.2022.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.htct.2022.11.001</ArticleId><ArticleId IdType="pmc">PMC9708632</ArticleId><ArticleId IdType="pubmed">36467112</ArticleId></ArticleIdList></Reference><Reference><Citation>Golinelli D., Boetto E., Maietti E., Fantini M.P. The association between ABO blood group and SARS-CoV-2 infection: A meta-analysis. PLoS ONE. 2020;15:e0239508. doi: 10.1371/journal.pone.0239508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0239508</ArticleId><ArticleId IdType="pmc">PMC7500631</ArticleId><ArticleId IdType="pubmed">32946531</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourali F., Afshari M., Alizadeh-Navaei R., Javidnia J., Moosazadeh M., Hessami A. Relationship between blood group and risk of infection and death in COVID-19: A live meta-analysis. New Microbes New Infect. 2020;37:100743. doi: 10.1016/j.nmni.2020.100743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2020.100743</ArticleId><ArticleId IdType="pmc">PMC7418722</ArticleId><ArticleId IdType="pubmed">32837730</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabrah S.M., Kabrah A.M., Flemban A.F., Abuzerr S. Systematic review and meta-analysis of the susceptibility of ABO blood group to COVID-19 infection. Transfus. Apher. Sci. 2021;60:103169. doi: 10.1016/j.transci.2021.103169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transci.2021.103169</ArticleId><ArticleId IdType="pmc">PMC8139534</ArticleId><ArticleId IdType="pubmed">34045120</ArticleId></ArticleIdList></Reference><Reference><Citation>Latz C.A., DeCarlo C., Boitano L., Png C.Y.M., Patell R., Conrad M.F., Eagleton M., Dua A. Blood type and outcomes in patients with COVID-19. Ann. Hematol. 2020;99:2113&#x2013;2118. doi: 10.1007/s00277-020-04169-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-020-04169-1</ArticleId><ArticleId IdType="pmc">PMC7354354</ArticleId><ArticleId IdType="pubmed">32656591</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu B.B., Gu D.Z., Yu J.N., Yang J., Shen W.Q. Association between ABO blood groups and COVID-19 infection, severity and demise: A systematic review and meta-analysis. Infect. Genet. Evol. 2020;84:104485. doi: 10.1016/j.meegid.2020.104485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2020.104485</ArticleId><ArticleId IdType="pmc">PMC7391292</ArticleId><ArticleId IdType="pubmed">32739464</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Zhang J., Jia L., Ai J., Yu Y., Wang M., Li P. ABO blood group influence COVID-19 infection: A meta-analysis. J. Infect. Dev. Ctries. 2021;15:1801&#x2013;1807. doi: 10.3855/jidc.13815.</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.13815</ArticleId><ArticleId IdType="pubmed">35044935</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N., Zhang T., Ma L., Zhang H., Wang H., Wei W., Pei H., Li H. The impact of ABO blood group on COVID-19 infection risk and mortality: A systematic review and meta-analysis. Blood Rev. 2021;48:100785. doi: 10.1016/j.blre.2020.100785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2020.100785</ArticleId><ArticleId IdType="pmc">PMC7834371</ArticleId><ArticleId IdType="pubmed">33309392</ArticleId></ArticleIdList></Reference><Reference><Citation>Abuawwad M.T., Taha M.J.J., Abu-Ismail L., Alrubasy W.A., Sameer S.K., Abuawwad I.T., Al-Bustanji Y., Nashwan A.J. Effects of ABO blood groups and RH-factor on COVID-19 transmission, course and outcome: A review. Front. Med. 2023;9:1045060. doi: 10.3389/fmed.2022.1045060.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1045060</ArticleId><ArticleId IdType="pmc">PMC9878296</ArticleId><ArticleId IdType="pubmed">36714134</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullerdiek J., Reisinger E., Rommel B., Dotzauer A. ABO blood groups and the risk of SARS-CoV-2 infection. Protoplasma. 2022;259:1381&#x2013;1395. doi: 10.1007/s00709-022-01754-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00709-022-01754-1</ArticleId><ArticleId IdType="pmc">PMC8973646</ArticleId><ArticleId IdType="pubmed">35364749</ArticleId></ArticleIdList></Reference><Reference><Citation>Soo K.M., Chung K.M., Mohd Azlan M.A.A., Lam J.Y., Ren J.W.X., Arvind J.J., Wong Y.P., Chee H.Y., Amin-Nordin S. The association of ABO and Rhesus blood type with the risks of developing SARS-CoV-2 infection: A meta-analysis. Trop. Biomed. 2022;39:126&#x2013;134. doi: 10.47665/tb.39.1.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.47665/tb.39.1.015</ArticleId><ArticleId IdType="pubmed">35507935</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Yang Y., Huang H., Li D., Gu D., Lu X., Zhang Z., Liu L., Liu T., Liu Y., et al. Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) Susceptibility. Clin. Infect. Dis. 2021;73:328&#x2013;331. doi: 10.1093/cid/ciaa1150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1150</ArticleId><ArticleId IdType="pmc">PMC7454371</ArticleId><ArticleId IdType="pubmed">32750119</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai X. ABO blood group predisposes to COVID-19 severity and cardiovascular diseases. Eur. J. Prev. Cardiol. 2020;27:1436&#x2013;1437. doi: 10.1177/2047487320922370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2047487320922370</ArticleId><ArticleId IdType="pmc">PMC7717262</ArticleId><ArticleId IdType="pubmed">32343152</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellinghaus D., Degenhardt F., Bujanda L., Buti M., Albillos A., Invernizzi P., Fern&#xe1;ndez J., Prati D., Baselli G., Asselta R., et al. Genome wide Association Study of Severe COVID-19 with Respiratory Failure. N. Engl. J. Med. 2020;383:1522&#x2013;1534. doi: 10.1056/NEJMoa2020283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2020283</ArticleId><ArticleId IdType="pmc">PMC7315890</ArticleId><ArticleId IdType="pubmed">32558485</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdulla S.A., Elawamy H.A., Mohamed N.A., Abduallah E.H., Amshahar H.A., Abuzaeid N.K., Eisa M.A., Osman M.E.M., Konozy E.H.E. Association of ABO blood types and clinical variables with COVID-19 infection severity in Libya. SAGE Open Med. 2023;11:20503121231187736. doi: 10.1177/20503121231187736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20503121231187736</ArticleId><ArticleId IdType="pmc">PMC10363681</ArticleId><ArticleId IdType="pubmed">37489137</ArticleId></ArticleIdList></Reference><Reference><Citation>Bari A., Ch A., Hareem S., Bano I., Rashid J., Sadiq M. Association of Blood Groups with the Severity and Outcome of COVID-19 Infection in Children. J. Coll. Physicians Surg. Pak. 2021;30:S57&#x2013;S59. doi: 10.29271/jcpsp.2021.01.S57.</Citation><ArticleIdList><ArticleId IdType="doi">10.29271/jcpsp.2021.01.S57</ArticleId><ArticleId IdType="pubmed">33650427</ArticleId></ArticleIdList></Reference><Reference><Citation>Marraccini C., Merolle L., Schiroli D., Razzoli A., Gavioli G., Iotti B., Baricchi R., Ottone M., Mancuso P., Rossi P.G. A cohort study on the biochemical and haematological parameters of Italian blood donors as possible risk factors of COVID-19 infection and severe disease in the pre- and post-Omicron period. PLoS ONE. 2023;18:e0294272. doi: 10.1371/journal.pone.0294272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0294272</ArticleId><ArticleId IdType="pmc">PMC10662768</ArticleId><ArticleId IdType="pubmed">37988390</ArticleId></ArticleIdList></Reference><Reference><Citation>Franchini M., Cruciani M., Mengoli C., Marano G., Candura F., Lopez N., Pati I., Pupella S., De Angelis V. ABO blood group and COVID-19: An updated systematic literature review and meta-analysis. Blood Transfus. 2021;19:317&#x2013;326. doi: 10.2450/2021.0049-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.2450/2021.0049-21</ArticleId><ArticleId IdType="pmc">PMC8297670</ArticleId><ArticleId IdType="pubmed">34059188</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Pel&#xe1;ez A., Busquets X., Rodrigo-Garc&#xed;a M., P&#xe9;rez-Urr&#xed;a E., Alonso T., Gir&#xf3;n R., Valenzuela C., Marcos C., Garc&#xed;a-Castillo E., et al. ABO blood group as a determinant of COVID-19 and Long COVID: An observational, longitudinal, large study. PLoS ONE. 2023;18:e0286769. doi: 10.1371/journal.pone.0286769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0286769</ArticleId><ArticleId IdType="pmc">PMC10237493</ArticleId><ArticleId IdType="pubmed">37267401</ArticleId></ArticleIdList></Reference><Reference><Citation>Kousathanas A., Pairo-Castineira E., Rawlik K., Stuckey A., Odhams C.A., Walker S., Russell C.D., Malinauskas T., Wu Y., Millar J., et al. Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature. 2022;607:97&#x2013;103. doi: 10.1038/s41586-022-04576-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04576-6</ArticleId><ArticleId IdType="pmc">PMC9259496</ArticleId><ArticleId IdType="pubmed">35255492</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly J.P., Meyer N.J., Shashaty M.G., Feng R., Lanken P.N., Gallop R., Kaplan S., Herlim M., Oz N.L., Hiciano I., et al. ABO blood type A is associated with increased risk of ARDS in whites following both major trauma and severe sepsis. Chest. 2014;145:753&#x2013;761. doi: 10.1378/chest.13-1962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.13-1962</ArticleId><ArticleId IdType="pmc">PMC3971970</ArticleId><ArticleId IdType="pubmed">24385226</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenti L., Villa S., Baselli G., Temporiti R., Bandera A., Scudeller L., Prati D. Association of ABO blood group and secretor phenotype with severe COVID-19. Transfusion. 2020;60:3067&#x2013;3070. doi: 10.1111/trf.16130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.16130</ArticleId><ArticleId IdType="pmc">PMC7675339</ArticleId><ArticleId IdType="pubmed">33009662</ArticleId></ArticleIdList></Reference><Reference><Citation>Mankelow T.J., Singleton B.K., Moura P.L., Stevens-Hernandez C.J., Cogan N.M., Gyorffy G., Kupzig S., Nichols L., Asby C., Pooley J., et al. Blood group type A secretors are associated with a higher risk of COVID-19 cardiovascular disease complications. EJHaem. 2021;2:175&#x2013;187. doi: 10.1002/jha2.180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jha2.180</ArticleId><ArticleId IdType="pmc">PMC8176350</ArticleId><ArticleId IdType="pubmed">34124710</ArticleId></ArticleIdList></Reference><Reference><Citation>Magwira C.A., Nndwamato N.P., Selabe G., Seheri M.L. Lewis a-b- histo-blood group antigen phenotype is predictive of severe COVID-19 in the black South African population group. Glycobiology. 2023;34:cwad090. doi: 10.1093/glycob/cwad090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cwad090</ArticleId><ArticleId IdType="pubmed">37950443</ArticleId></ArticleIdList></Reference><Reference><Citation>Moslemi C., S&#xe6;kmose S., Larsen R., Brodersen T., Didriksen M., Hjalgrim H., Banasik K., Nielsen K.R., Bruun M.T., Dowsett J., et al. A large cohort study of the effects of Lewis, ABO, 13 other blood groups, and secretor status on COVID-19 susceptibility, severity, and long COVID-19. Transfusion. 2023;63:47&#x2013;58. doi: 10.1111/trf.17170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.17170</ArticleId><ArticleId IdType="pmc">PMC9874484</ArticleId><ArticleId IdType="pubmed">36271437</ArticleId></ArticleIdList></Reference><Reference><Citation>Matzhold E.M., Berghold A., Bemelmans M.K.B., Banfi C., Stelzl E., Kessler H.H., Steinmetz I., Krause R., Wurzer H., Schlenke P., et al. Lewis and ABO histo-blood types and the secretor status of patients hospitalized with COVID-19 implicate a role for ABO antibodies in susceptibility to infection with SARS-CoV-2. Transfusion. 2021;61:2736&#x2013;2745. doi: 10.1111/trf.16567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.16567</ArticleId><ArticleId IdType="pmc">PMC8447157</ArticleId><ArticleId IdType="pubmed">34151460</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe9;rard C., Maggipinto G., Minon J.M. COVID-19 and ABO blood group: Another viewpoint. Br. J. Haematol. 2020;190:e93&#x2013;e94. doi: 10.1111/bjh.16884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16884</ArticleId><ArticleId IdType="pmc">PMC7283642</ArticleId><ArticleId IdType="pubmed">32453863</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel R., Bloch E.M., Pirenne F., Al-Riyami A.Z., Crowe E., Dau L., Land K., Townsend M., Jecko T., Rahimi-Levene N., et al. ABO blood group and COVID-19: A review on behalf of the ISBT COVID-19 Working Group. Vox Sang. 2021;116:849&#x2013;861. doi: 10.1111/vox.13076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/vox.13076</ArticleId><ArticleId IdType="pmc">PMC8014128</ArticleId><ArticleId IdType="pubmed">33578447</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortensen S.J., Gjerding L.A.M., Exsteen M.B., Benfield T., Larsen R., Clausen F.B., Rieneck K., Krog G.R., Eriksson F., Dziegiel M.H. Reduced susceptibility to COVID-19 associated with ABO blood group and pre-existing anti-A and anti-B antibodies. Immunobiology. 2023;228:152399. doi: 10.1016/j.imbio.2023.152399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2023.152399</ArticleId><ArticleId IdType="pmc">PMC10228156</ArticleId><ArticleId IdType="pubmed">37329825</ArticleId></ArticleIdList></Reference><Reference><Citation>Khder Mustafa S., Zrar Omar S., Kamal Ahmad K., Basil Khudhur L. The association of ABO blood group distribution and clinical characteristics in patients with SARS-CoV-2. J. Infect. Dev. Ctries. 2023;17:18&#x2013;22. doi: 10.3855/jidc.17430.</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.17430</ArticleId><ArticleId IdType="pubmed">36795922</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiani A.S., Zizza A., Banchelli F., Gigante M., De Feo M.L., Ostuni A., Marinelli V., Quagnano S., Negro P., Di Renzo N., et al. Association between ABO blood groups and SARS-CoV-2 infection in blood donors of Puglia region. Ann. Hematol. 2023;102:2923&#x2013;2931. doi: 10.1007/s00277-023-05331-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-023-05331-1</ArticleId><ArticleId IdType="pmc">PMC10492875</ArticleId><ArticleId IdType="pubmed">37442822</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillon P., Cl&#xe9;ment M., S&#xe9;bille V., Rivain J.-G., Chou C.-F., Ruvo&#xeb;n-Clouet N., Le Pendu J. Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. Glycobiology. 2008;18:1085&#x2013;1093. doi: 10.1093/glycob/cwn093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cwn093</ArticleId><ArticleId IdType="pmc">PMC7108609</ArticleId><ArticleId IdType="pubmed">18818423</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez-Valencia M., Leache L., Librero J., Jeric&#xf3; C., Germ&#xe1;n M.E., Garc&#xed;a-Erce J.A. ABO blood group and risk of COVID-19 infection and complications: A systematic review and meta-analysis. Transfusion. 2022;62:493&#x2013;505. doi: 10.1111/trf.16748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.16748</ArticleId><ArticleId IdType="pmc">PMC8661771</ArticleId><ArticleId IdType="pubmed">34773411</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamayo-Velasco &#xc1;., Pe&#xf1;arrubia-Ponce M.J., &#xc1;lvarez F.J., de la Fuente I., P&#xe9;rez-Gonz&#xe1;lez S., Andaluz-Ojeda D. ABO Blood System and COVID-19 Susceptibility: Anti-A and Anti-B Antibodies Are the Key Points. Front. Med. 2022;9:882477. doi: 10.3389/fmed.2022.882477.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.882477</ArticleId><ArticleId IdType="pmc">PMC9081929</ArticleId><ArticleId IdType="pubmed">35547235</ArticleId></ArticleIdList></Reference><Reference><Citation>Lilova Z., Hassan F., Riaz M., Ironside J., Ken-Dror G., Han T., Sharma P. Blood group and ischemic stroke, myocardial infarction, and peripheral vascular disease: A meta-analysis of over 145,000 cases and 2,000,000 controls. J. Stroke Cerebrovasc. Dis. 2023;32:107215. doi: 10.1016/j.jstrokecerebrovasdis.2023.107215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2023.107215</ArticleId><ArticleId IdType="pubmed">37336185</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu O., Bayoumi N., Vickers M.A., Clark P. ABO(H) blood groups and vascular disease: A systematic review and meta-analysis. J. Thromb. Haemost. 2008;6:62&#x2013;69. doi: 10.1111/j.1538-7836.2007.02818.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2007.02818.x</ArticleId><ArticleId IdType="pubmed">17973651</ArticleId></ArticleIdList></Reference><Reference><Citation>Par&#xe9; G., Chasman D.I., Kellogg M., Zee R.Y.L., Rifai N., Badola S., Miletich J.P., Ridker P.M. Novel association of ABO histo-blood group antigen with soluble ICAM-1: Results of a genome-wide association study of 6578 women. PLoS Genet. 2008;4:e1000118. doi: 10.1371/journal.pgen.1000118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000118</ArticleId><ArticleId IdType="pmc">PMC2432033</ArticleId><ArticleId IdType="pubmed">18604267</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendu J.L., Breiman A., Rocher J., Dion M., Ruvo&#xeb;n-Clouet N. ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data. Viruses. 2021;13:160. doi: 10.3390/v13020160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020160</ArticleId><ArticleId IdType="pmc">PMC7911989</ArticleId><ArticleId IdType="pubmed">33499228</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamayo-Velasco &#xc1;., Ponce M.J.P., &#xc1;lvarez F.J., Gonzalo-Benito H., de la Fuente I., P&#xe9;rez-Gonz&#xe1;lez S., Rico L., Garc&#xed;a M.T.J., Rodr&#xed;guez A.S., Villaizan M.H., et al. Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can. Front. Immunol. 2021;12:726283. doi: 10.3389/fimmu.2021.726283.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.726283</ArticleId><ArticleId IdType="pmc">PMC8548690</ArticleId><ArticleId IdType="pubmed">34721388</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoiland R.L., Fergusson N.A., Mitra A.R., Griesdale D.E.G., Devine D.V., Stukas S., Cooper J., Thiara S., Foster D., Chen L.Y.C., et al. The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19. Blood Adv. 2020;4:4981&#x2013;4989. doi: 10.1182/bloodadvances.2020002623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020002623</ArticleId><ArticleId IdType="pmc">PMC7594392</ArticleId><ArticleId IdType="pubmed">33057633</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S.-C., Arthur C.M., Jan H.-M., Garcia-Beltran W.F., Patel K.R., Rathgeber M.F., Verkerke H.P., Cheedarla N., Jajosky R.P., Paul A., et al. Blood group A enhances SARS-CoV-2 infection. Blood. 2023;142:742&#x2013;747. doi: 10.1182/blood.2022018903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2022018903</ArticleId><ArticleId IdType="pmc">PMC10294591</ArticleId><ArticleId IdType="pubmed">37367252</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva-Filho J.C., Melo C.G.F., Oliveira J.L. The influence of ABO blood groups on COVID-19 susceptibility and severity: A molecular hypothesis based on carbohydrate-carbohydrate interactions. Med. Hypotheses. 2020;144:110155. doi: 10.1016/j.mehy.2020.110155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110155</ArticleId><ArticleId IdType="pmc">PMC7395945</ArticleId><ArticleId IdType="pubmed">33254482</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nat. Med. 2023;29:2347&#x2013;2357. doi: 10.1038/s41591-023-02521-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing T.K.P., Garg P., Clark A., Ntatsaki E., Vassiliou V.S. Risk Factors Associated with Post-COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern. Med. 2023;183:566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicentini C., Bordino V., Cornio A.R., Meddis D., Ditommaso S., Giacomuzzi M., Memoli G., Bert F., Zotti C.M. Does ABO blood group influence antibody response to SARS-CoV-2 vaccination? Vox Sang. 2022;117:754&#x2013;755. doi: 10.1111/vox.13241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/vox.13241</ArticleId><ArticleId IdType="pubmed">34962291</ArticleId></ArticleIdList></Reference><Reference><Citation>Allan J.D., McMillan D., Levi M.L. COVID-19 mRNA Vaccination, ABO Blood Type and the Severity of Self-Reported Reactogenicity in a Large Healthcare System: A Brief Report of a Cross-Sectional Study. Cureus. 2021;13:e20810. doi: 10.7759/cureus.20810.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.20810</ArticleId><ArticleId IdType="pmc">PMC8799399</ArticleId><ArticleId IdType="pubmed">35141068</ArticleId></ArticleIdList></Reference><Reference><Citation>Alessa M.Y., Aledili F.J., Alnasser A.A., Aldharman S.S., Al Dehailan A.M., Abuseer H.O., Saleh A.A.A., Alsalem H.A., Alsadiq H.M., Alsultan A.S. The Side Effects of COVID-19 Vaccines and Its Association with ABO Blood Type Among the General Surgeons in Saudi Arabia. Cureus. 2022;14:e23628. doi: 10.7759/cureus.23628.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.23628</ArticleId><ArticleId IdType="pmc">PMC9050174</ArticleId><ArticleId IdType="pubmed">35494934</ArticleId></ArticleIdList></Reference><Reference><Citation>Almalki O.S., Santali E.Y., Alhothali A.A., Ewis A.A., Shady A., Fathelrahman A.I., Abdelwahab S.F. The role of blood groups, vaccine type and gender in predicting the severity of side effects among university students receiving COVID-19 vaccines. BMC Infect. Dis. 2023;23:378. doi: 10.1186/s12879-023-08363-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08363-0</ArticleId><ArticleId IdType="pmc">PMC10242595</ArticleId><ArticleId IdType="pubmed">37280542</ArticleId></ArticleIdList></Reference><Reference><Citation>Deleers M., Breiman A., Daubie V., Maggetto C., Barreau I., Besse T., Cl&#xe9;menceau B., Ruvo&#xeb;n-Clouet N., Fils J.-F., Maillart E., et al. COVID-19 and blood groups: ABO antibody levels may also matter. Int. J. Infect. Dis. 2021;104:242&#x2013;249. doi: 10.1016/j.ijid.2020.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.12.025</ArticleId><ArticleId IdType="pmc">PMC7832075</ArticleId><ArticleId IdType="pubmed">33326874</ArticleId></ArticleIdList></Reference><Reference><Citation>Wacklin P., M&#xe4;kivuokko H., Alakulppi N., Nikkil&#xe4; J., Tenkanen H., R&#xe4;bin&#xe4; J., Partanen J., Aranko K., M&#xe4;tt&#xf6; J. Secretor genotype (FUT2 gene) is strongly associated with the composition of Bifidobacteria in the human intestine. PLoS ONE. 2011;6:e20113. doi: 10.1371/journal.pone.0020113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020113</ArticleId><ArticleId IdType="pmc">PMC3098274</ArticleId><ArticleId IdType="pubmed">21625510</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe4;kivuokko H., Lahtinen S.J., Wacklin P., Tuovinen E., Tenkanen H., Nikkil&#xe4; J., Bj&#xf6;rklund M., Aranko K., Ouwehand A.C., M&#xe4;tt&#xf6; J. Association between the ABO blood group and the human intestinal microbiota composition. BMC Microbiol. 2012;12:94. doi: 10.1186/1471-2180-12-94.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-12-94</ArticleId><ArticleId IdType="pmc">PMC3485159</ArticleId><ArticleId IdType="pubmed">22672382</ArticleId></ArticleIdList></Reference><Reference><Citation>A&#x11f;ag&#xfc;nd&#xfc;z D., Cocozza E., Cemali &#xd6;., Bayaz&#x131;t A.D., Nan&#xec; M.F., Cerqua I., Morgillo F., Sayg&#x131;l&#x131; S.K., Canani R.B., Amero P., et al. Understanding the role of the gut microbiome in gastrointestinal cancer: A review. Front. Pharmacol. 2023;14:1130562. doi: 10.3389/fphar.2023.1130562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2023.1130562</ArticleId><ArticleId IdType="pmc">PMC9903080</ArticleId><ArticleId IdType="pubmed">36762108</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H., Liu M., Cao J., Li X., Fan D., Xia Y., Lu X., Li J., Ju D., Zhao H. The Dynamic Interplay between the Gut Microbiota and Autoimmune Diseases. J. Immunol. Res. 2019;2019:7546047. doi: 10.1155/2019/7546047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/7546047</ArticleId><ArticleId IdType="pmc">PMC6854958</ArticleId><ArticleId IdType="pubmed">31772949</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B.L., He N., Huang Y.B., Song F.J., Chen K.X. ABO blood groups and risk of cancer: A systematic review and meta-analysis. Asian Pac. J. Cancer Prev. 2014;15:4643&#x2013;4650. doi: 10.7314/APJCP.2014.15.11.4643.</Citation><ArticleIdList><ArticleId IdType="doi">10.7314/APJCP.2014.15.11.4643</ArticleId><ArticleId IdType="pubmed">24969898</ArticleId></ArticleIdList></Reference><Reference><Citation>Durack J., Lynch S.V., Nariya S., Bhakta N.R., Beigelman A., Castro M., Dyer A.-M., Israel E., Kraft M., Martin R.J., et al. National Heart, Lung and Blood Institute&#x2019;s &#x201c;AsthmaNet&#x201d;. Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment. J. Allergy Clin. Immunol. 2017;140:63&#x2013;75. doi: 10.1016/j.jaci.2016.08.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2016.08.055</ArticleId><ArticleId IdType="pmc">PMC5502827</ArticleId><ArticleId IdType="pubmed">27838347</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatiwada S., Subedi A. Lung microbiome and coronavirus disease 2019 (COVID-19): Possible link and implications. Hum. Microb. J. 2020;17:100073. doi: 10.1016/j.humic.2020.100073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humic.2020.100073</ArticleId><ArticleId IdType="pmc">PMC7405772</ArticleId><ArticleId IdType="pubmed">32835135</ArticleId></ArticleIdList></Reference><Reference><Citation>Su S., Guo L., Ma T., Sun Y., Song A., Wang W., Gu X., Wu W., Xie X., Zhang L., et al. Association of ABO blood group with respiratory disease hospitalization and severe outcomes: A retrospective cohort study in blood donors. Int. J. Infect. Dis. 2022;122:21&#x2013;29. doi: 10.1016/j.ijid.2022.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.05.019</ArticleId><ArticleId IdType="pubmed">35562043</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby P., Nguyen N.Y., Dunstan S.J., Baillie J.K. The role of host genetics in susceptibility to influenza: A systematic review. PLoS ONE. 2012;7:e33180. doi: 10.1371/journal.pone.0033180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0033180</ArticleId><ArticleId IdType="pmc">PMC3305291</ArticleId><ArticleId IdType="pubmed">22438897</ArticleId></ArticleIdList></Reference><Reference><Citation>Raza M.W., Blackwell C.C., Molyneaux P., James V.S., Ogilvie M.M., Inglis J.M., Weir D.M. Association between secretor status and respiratory viral illness. BMJ. 1991;303:815&#x2013;818. doi: 10.1136/bmj.303.6806.815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.303.6806.815</ArticleId><ArticleId IdType="pmc">PMC1671169</ArticleId><ArticleId IdType="pubmed">1932971</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie J.S., Fimmel P.J. The effect of ABO blood groups on the incidence of epidemic influenza and on the response to live attenuated and detergent split influenza virus vaccines. J. Hyg. 1978;80:21&#x2013;30. doi: 10.1017/S0022172400053365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022172400053365</ArticleId><ArticleId IdType="pmc">PMC2129976</ArticleId><ArticleId IdType="pubmed">621379</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>